Correlation of P-glycoprotein expression and function in childhood acute leukemia: A Children's Cancer Group Study

Blood

Volumn 88, Issue 1, 1996, Pages 309-318

  Ivy, S Percy ^a,b   Olshefski, Randal S ^a   Taylor, Barbara J ^a   Patel, Kantilal M ^a   Reaman, Gregory H ^a  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; RHODAMINE 123; VERAPAMIL; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CANCER RECURRENCE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0029901696     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.309.309     Document Type: Article

References (46)

1. Pui C-H: Childhood Ieukemias. N Engl J Med 332:1618, 1995
2. Poplack DG, Reaman GH: Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am 35:903, 1988
3. Poplack DG: Acute lymphoblastic leukemia, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 1). Philadelphia, PA, Lippincott, 1989, p 323
4. Chen C-j, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr-1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381, 1986
5. Gros P, Neriah YB, Croop JM, Housman DE: Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323:728, 1986
6. Gros P, Croop J, Roninson I, Varshavsky A, Housman DE: Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells. Proc Natl Acad Sci USA 83:337, 1986
7. Roninson IB, Abelson HT, Housman DE, Howell N, Varshavsky A: Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells. Nature 309:626, 1984
8. Roninson IB: Detection and mapping of homologous, repeated and amplified DNA sequences by DNA renaturation in agarose gels. Nucleic Acids Res 11:5413, 1983
9. Gros P, Croop J, Housman D: Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371, 1986
10. Gill DR, Hyde SC, Higgins CF, Valverde MA, Mintenig GM, Sepulveda FV: Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71:23, 1992
11. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967, 1981
12. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y: Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res 43:2267, 1983
13. Mechetner EB, Roninson IB: Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci USA 89:5824, 1992
14. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug effux pump, in human hematopoietic stem cells. Cell 66:85, 1991
15. Chaudhary PM, Mechetner EB, Roninson IB: Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735, 1992
16. Arceci RJ: Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 81:2215, 1993
17. Salmon SE, Dalton WS, Grogan TM, Plezia P, Lehnert M, Roe DJ, Miller TP: Multidrug-resistant myeloma: Laboratory and clinical effects of verapamil as a chemosensitizer. Blood 78:44, 1991
18. Ozols RF, Cunnion RE, Klecker RW, Hamilton TC, Ostchega Y, Parrillo JE, Young RC: Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. J Clin Oncol 5:641, 1987
19. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BGM, Taylor CW, Miller TP, Salmon SE: Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: Detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7:415, 1989
20. Cairo MS, Siegel S, Anas N, Sender L: Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug resistant pediatric tumors. Cancer Res 49:1063, 1989
21. Erlichman C, Moore M, Thiessen JJ, Kerr IG, Walker S, Goodman P, Bjarnason G, DeAngelis C, Bunting P: Phase I pharmacokinetic study of Cyclosporin A combined with doxorubicin. Cancer Res 53:4837, 1993
22. List AF, Spier CM, Greer J, Wolff S, Hutter J, Dorr R, Salmon S, Futscher B, Baier M, Dalton W: Phase I/II trial of cyclosporine as a chemotherapy resistance modifier in acute leukemia. J Clin Oncol 11:1652, 1993
23. Boesch D, Gaveriaux C, Jachez B, Pourtier-Manzanedo A, Bollinger P, Loor F: In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res 51:4226, 1991
24. Twentyman PR, Bleehen NM: Resistance modification by PSC-833, a novel non-immunosuppressive Cyclosporin A. Eur J Cancer 1991:1639, 1991
25. Dinndorf PA, Reaman GH: Acute lymphoblastic leukemia in infants: Evidence for B cell origin of disease by use of monoclonal antibody phenotyping. Blood 68:975, 1986
26. Alley M, Scudiero D, Monks A, Hursey M, Czerwinski M, Fine D, Abbott B, Mayo J, Shoemaker R, Boyd M: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589, 1988
27. Tsuruo T, Sugimoto Y, Hamada H, Roninson I, Okumure M, Adachi K, Morishima Y, Ohno R: Detection of multidrug resistance marker, P-glycoprotein and mdr1 mRNA, in human leukemia cells. Jpn J Cancer Res 78:1415, 1987
28. Hamada H, Miura K, Ariyoshi K, Heike Y, Sato S, Kameyama K-Z, Kurosawa Y, Tsuruo T: Mouse-human chimeric antibody against the multidrug transporter P-glycoprotein. Cancer Res 50:3167, 1990
29. Ross DD, Thompson BW, Ordonez JV, C JC: Improvement of flow-cytometric detection of multidrug-resistant cells by cellvolume normalization of intracellular daunorubicin content. Cytometry 10:185, 1989
30. Ross DD, Wooten PJ, Sridhara R, Ordonez JV, Lee EJ, Schiffer CA: Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or Cyclosporin A in blast cells from patients with previously untreated acute myleoid leukemia. Blood 82:1288, 1993
31. Kessel D, Beck WT, Kukuruga D, Schulz V: Characterization of multidrug resistance by fluorescent dyes. Cancer Res 51:4665, 1991
32. Young IT: Proof without prejudice: Use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 25:935, 1977
33. Ault KA: Detection of small numbers of monoclonal B lymphocytes in the blood of patients with lymphoma. N Engl J Med 300:1401, 1979
34. Armitage P: Statistical Methods in Medical Research. New York, NY, Wiley, 1971
35. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650, 1992
36. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen THM, van Kalken CK, Slovak ML, de Vries EGE, van der Valk P, Meijer CJL, Pinedo HM: Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 53:1475, 1993
37. Sonneveld P, van Dongen JM, Hagemeijer A, van Lom K, Nooter K, Schoester M, Adriaansen HJ, Tsuruo T, de Leeuw K: High expression of the multidrug resistance P-glycoprotein in highrisk myelodysplasia is associated with immature phenotype. Leukemia 7:963, 1992
38. te Boekhorst PAW, de Leeuw K, Schoester M, Wittebol S, Nooter K, Hagemeijer A, Lowenberg B, Sonneveld P: Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood 82:3157, 1993
39. Miwa H, Kita K, Nishii K, Monta N, Takakura N, Ohishi K, Mahmud N, Kageyama S, Fukumoto M, Shirakawa S: Expression of MDR1 gene in acute leukemia cells: Association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia. Blood 82:3445, 1993
40. Sievers EL, Smith OF, Lee JW, Woods WG, Bleyer WA, Bernstein ID: Cell surface expression of the multidrug resistance P-glycoprotein (P-170) in pediatric acute myeloid leukemia fails to define a poor prognostic group. Blood 84:303a, 1994 (abstr, suppl 1)
41. Gruber A, Vitols S, Norgren S, Arestrom I, Peterson C, Bjorkholm M, Reizenstein P, Luthman H: Quantitative determination of mdr1 gene expression in leukemic cells from patients with acute leukemia. Br J Cancer 66:266, 1992
42. Ino T, Miyazaki H, Isogai M, Nomura T, Tsuzuki M, Tsuruo T, Ezaki K, Hirano M: Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: Results of molecular and functional assays, and correlation with treatment outcome. Leukemia 8:1492, 1994
43. Leith CP, Chen I-M, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL: Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: Identification of discordant MDR-/efflux+ and MDR+/effluxcases. Blood 86:2329, 1995
44. Ivy SP, Smith JK, Speciale A, Sather H, Hammond GD, Reaman GH: Detection of mdr1 gene expression using polymerase chain reaction (PCR) in childhood acute lymphoblastic leukemia (ALL) at diagnosis. Proc Am Assoc Cancer Res 33:473a, 1992 (abstr)
45. Lamy T, Drenou B, Grulois I, Fardel O, Jacquelinet C, Goasguen J, Dauriac C, Amiot L, Bernard M, Fauchet R, Le Prise P-Y: Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay. Leukemia 9:1549, 1995
46. Ludescher C, Eisterer W, Hilbe W, Gotwald M, Hofmann J, Zabernigg A, Cianfriglia M, Thaler J: Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia. Leukemia 9:350, 1995